Skip to main content

Table 2 Patient Demographics and Disease Severity

From: Development and validation of a psoriasis treatment acceptability measure through group concept mapping

 

Study 1: GCM

(N = 20)

Study 2: GCM

(N = 20)

Study 2: CD Interview

(N = 20)

Study 2: Online Survey (N = 198)

Sex, n (%)

Female

11 (55)

16 (80)

15 (75)

111 (56)

Male

9 (45)

4 (20)

5 (25)

87 (44)

Age, years

Mean (SD)

50.6 (14.4)

45.6 (18.4)

51.1 (19.0)

39.3 (12.7)

Min/Max

28/85

25/84

19/80

18/78

Race, n (%)

White/Caucasian

17 (85)

15 (75)

5 (25)

77 (39)

Black/African-American

3 (15)

5 (25)

11 (55)

99 (50)

Asian/Asian-American

0

0

1 (5)

2 (1)

Other

0

0

3 (15)

20 (10)

Ethnicity, n (%)*

Hispanic/Latino

0

0

1 (5)

21 (11)

Not Hispanic/Latino

20 (100)

20 (100)

18 (90)

177 (89)

Disease Severity, Clinician-rated, n (%)

None/Very mild

-

-

-

1 (< 1%)

Mild

0

20 (100)

5 (25)

63 (32)

Moderate

15 (75)

0

5 (25)

74 (37)

Severe

5 (25)

0

4 (20)

46 (23)

Very Severe

0

0

6 (30)

14 (7)

  1. *1 missing in Study 2: CD Interview